Skip to main content
Journal cover image

Pharmacologic treatment of posttraumatic stress disorder: a focus on antipsychotic use.

Publication ,  Journal Article
Ahearn, EP; Krohn, A; Connor, KM; Davidson, JRT
Published in: Ann Clin Psychiatry
2003

To review the literature on the pharmacologic treatment of posttraumatic stress disorder (PTSD), with a focus on reports of antipsychotic use for this illness. A MEDLINE search (1966-Oct 2002) for English only articles about pharmacologic treatment of PTSD. Antipsychotic medications are being used with some frequency for PTSD. There are few studies and scant evidence to recommend the traditional antipsychotics. There are a number of reports (mostly case reports and open trials) in which atypical antipsychotics improved sleep and decreased the frequency of nightmares and flashbacks. Some studies showed global improvement across symptom clusters. The newer atypical antipsychotics show promise for the treatment of PTSD, mainly ameliorating intrusive symptoms. The paucity of double-blind studies prevents firm conclusions, however, this class of medications may be useful particularly for refractory symptoms.

Duke Scholars

Published In

Ann Clin Psychiatry

DOI

ISSN

1040-1237

Publication Date

2003

Volume

15

Issue

3-4

Start / End Page

193 / 201

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Stress Disorders, Post-Traumatic
  • Sleep
  • Psychiatry
  • Humans
  • Drug Utilization
  • Dreams
  • Combat Disorders
  • Clinical Trials as Topic
  • Antipsychotic Agents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ahearn, E. P., Krohn, A., Connor, K. M., & Davidson, J. R. T. (2003). Pharmacologic treatment of posttraumatic stress disorder: a focus on antipsychotic use. Ann Clin Psychiatry, 15(3–4), 193–201. https://doi.org/10.1023/b:acli.0000008173.01153.4e
Ahearn, Eileen P., Amy Krohn, Kathryn M. Connor, and Jonathan R. T. Davidson. “Pharmacologic treatment of posttraumatic stress disorder: a focus on antipsychotic use.Ann Clin Psychiatry 15, no. 3–4 (2003): 193–201. https://doi.org/10.1023/b:acli.0000008173.01153.4e.
Ahearn EP, Krohn A, Connor KM, Davidson JRT. Pharmacologic treatment of posttraumatic stress disorder: a focus on antipsychotic use. Ann Clin Psychiatry. 2003;15(3–4):193–201.
Ahearn, Eileen P., et al. “Pharmacologic treatment of posttraumatic stress disorder: a focus on antipsychotic use.Ann Clin Psychiatry, vol. 15, no. 3–4, 2003, pp. 193–201. Pubmed, doi:10.1023/b:acli.0000008173.01153.4e.
Ahearn EP, Krohn A, Connor KM, Davidson JRT. Pharmacologic treatment of posttraumatic stress disorder: a focus on antipsychotic use. Ann Clin Psychiatry. 2003;15(3–4):193–201.
Journal cover image

Published In

Ann Clin Psychiatry

DOI

ISSN

1040-1237

Publication Date

2003

Volume

15

Issue

3-4

Start / End Page

193 / 201

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Stress Disorders, Post-Traumatic
  • Sleep
  • Psychiatry
  • Humans
  • Drug Utilization
  • Dreams
  • Combat Disorders
  • Clinical Trials as Topic
  • Antipsychotic Agents